Frontiers Sep 17 2025 GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes - helping stabilize blood glucose and lose weight which contributes to diabetes complications. But not everyone benefits equally. Scientists monitoring 92 individuals with diabetes in Japan over their first year of taking GLP-1 drugs found that people's reasons for overeating may affect the success of these therapies. Individuals who overeat in response to the sight or smell of tasty food were